Mark Ginski

965 total citations
10 papers, 765 citations indexed

About

Mark Ginski is a scholar working on Molecular Biology, Pharmaceutical Science and Oncology. According to data from OpenAlex, Mark Ginski has authored 10 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Pharmaceutical Science and 3 papers in Oncology. Recurrent topics in Mark Ginski's work include Dendrimers and Hyperbranched Polymers (3 papers), Drug Solubulity and Delivery Systems (3 papers) and RNA Interference and Gene Delivery (3 papers). Mark Ginski is often cited by papers focused on Dendrimers and Hyperbranched Polymers (3 papers), Drug Solubulity and Delivery Systems (3 papers) and RNA Interference and Gene Delivery (3 papers). Mark Ginski collaborates with scholars based in United States and Canada. Mark Ginski's co-authors include Mohamed E. H. ElSayed, Hamidreza Ghandehari, Christopher A. Rhodes, James E. Polli, Robert Somerville, Amir P. Tamiz, Blake Paterson, Joseph A. Murray, Shobha Gopalakrishnan and Şefik Ş. Alkan and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Psychopharmacology.

In The Last Decade

Mark Ginski

10 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Ginski United States 10 376 260 201 86 84 10 765
Ahmed H. Hikal United States 14 139 0.4× 64 0.2× 220 1.1× 18 0.2× 45 0.5× 31 541
Libero Italo Giannola Italy 18 234 0.6× 17 0.1× 540 2.7× 51 0.6× 103 1.2× 61 1.2k
P. M. Hardy United Kingdom 12 418 1.1× 20 0.1× 27 0.1× 60 0.7× 190 2.3× 21 793
T Wheatley United States 13 167 0.4× 10 0.0× 149 0.7× 47 0.5× 35 0.4× 18 679
Majid Tabbakhian Iran 13 281 0.7× 17 0.1× 560 2.8× 22 0.3× 41 0.5× 29 847
Ander Estella‐Hermoso de Mendoza Spain 19 694 1.8× 10 0.0× 139 0.7× 103 1.2× 84 1.0× 27 1.2k
Gopal Venkatesh Shavi India 16 195 0.5× 43 0.2× 329 1.6× 31 0.4× 43 0.5× 21 680
Yongjiu Lv China 16 255 0.7× 14 0.1× 319 1.6× 37 0.4× 64 0.8× 17 845

Countries citing papers authored by Mark Ginski

Since Specialization
Citations

This map shows the geographic impact of Mark Ginski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ginski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ginski more than expected).

Fields of papers citing papers by Mark Ginski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Ginski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ginski. The network helps show where Mark Ginski may publish in the future.

Co-authorship network of co-authors of Mark Ginski

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Ginski. A scholar is included among the top collaborators of Mark Ginski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Ginski. Mark Ginski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Gopalakrishnan, Shobha, Malarvizhi Durai, Kelly M. Kitchens, et al.. (2012). Larazotide acetate regulates epithelial tight junctions in vitro and in vivo. Peptides. 35(1). 86–94. 89 indexed citations
2.
Gopalakrishnan, Sandeep, Amir P. Tamiz, Rosa A. Carrasco, et al.. (2008). Mechanism of action of ZOT-derived peptide AT-1002, a tight junction regulator and absorption enhancer. International Journal of Pharmaceutics. 365(1-2). 121–130. 68 indexed citations
3.
Ferraris, Dana, Mark Ginski, Liang Shi, et al.. (2003). Design and synthesis of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. part 4: Biological evaluation of imidazobenzodiazepines as potent PARP-1 inhibitors for treatment of ischemic injuries. Bioorganic & Medicinal Chemistry. 11(17). 3695–3707. 45 indexed citations
4.
ElSayed, Mohamed E. H., Christopher A. Rhodes, Mark Ginski, & Hamidreza Ghandehari. (2003). Transport mechanism(s) of poly (amidoamine) dendrimers across Caco-2 cell monolayers. International Journal of Pharmaceutics. 265(1-2). 151–157. 101 indexed citations
5.
ElSayed, Mohamed E. H., Mark Ginski, Christopher A. Rhodes, & Hamidreza Ghandehari. (2003). Influence of Surface Chemistry of Poly(Amidoamine) Dendrimers on Caco-2 Cell Monolayers. Journal of Bioactive and Compatible Polymers. 18(1). 7–22. 42 indexed citations
6.
ElSayed, Mohamed E. H., Mark Ginski, Christopher A. Rhodes, & Hamidreza Ghandehari. (2002). Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers. Journal of Controlled Release. 81(3). 355–365. 205 indexed citations
7.
Ginski, Mark. (1999). Prediction of dissolution–absorption relationships from a dissolution/Caco-2 system. International Journal of Pharmaceutics. 177(1). 117–125. 64 indexed citations
8.
Ginski, Mark, et al.. (1999). Prediction of dissolution-absorption relationships from a continuous dissolution/Caco-2 system. PubMed. 1(2). 27–38. 46 indexed citations
9.
Polli, James E. & Mark Ginski. (1998). Human Drug Absorption Kinetics and Comparison to Caco-2 Monolayer Permeabilities. Pharmaceutical Research. 15(1). 47–52. 29 indexed citations
10.
Ginski, Mark, et al.. (1994). Sensitive and rapid behavioral differentiation ofN-methyl-d-aspartate receptor antagonists. Psychopharmacology. 114(4). 573–582. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026